Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

731 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Redefining outcomes in immune TTP: an international working group consensus report.
Cuker A, Cataland SR, Coppo P, de la Rubia J, Friedman KD, George JN, Knoebl PN, Kremer Hovinga JA, Lämmle B, Matsumoto M, Pavenski K, Peyvandi F, Sakai K, Sarode R, Thomas MR, Tomiyama Y, Veyradier A, Westwood JP, Scully M. Cuker A, et al. Among authors: peyvandi f. Blood. 2021 Apr 8;137(14):1855-1861. doi: 10.1182/blood.2020009150. Blood. 2021. PMID: 33529333 Free article.
ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases.
Rieger M, Mannucci PM, Kremer Hovinga JA, Herzog A, Gerstenbauer G, Konetschny C, Zimmermann K, Scharrer I, Peyvandi F, Galbusera M, Remuzzi G, Böhm M, Plaimauer B, Lämmle B, Scheiflinger F. Rieger M, et al. Among authors: peyvandi f. Blood. 2005 Aug 15;106(4):1262-7. doi: 10.1182/blood-2004-11-4490. Epub 2005 May 12. Blood. 2005. PMID: 15890682 Free article.
Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS-13).
Tripodi A, Peyvandi F, Chantarangkul V, Palla R, Afrasiabi A, Canciani MT, Chung DW, Ferrari S, Fujimura Y, Karimi M, Kokame K, Kremer Hovinga JA, Lämmle B, de Meyer SF, Plaimauer B, Vanhoorelbeke K, Varadi K, Mannucci PM. Tripodi A, et al. Among authors: peyvandi f. J Thromb Haemost. 2008 Sep;6(9):1534-41. doi: 10.1111/j.1538-7836.2008.03099.x. Epub 2008 Jul 26. J Thromb Haemost. 2008. PMID: 18662260 Free PMC article.
ADAMTS-13 assays in thrombotic thrombocytopenic purpura.
Peyvandi F, Palla R, Lotta LA, Mackie I, Scully MA, Machin SJ. Peyvandi F, et al. J Thromb Haemost. 2010 Apr;8(4):631-40. doi: 10.1111/j.1538-7836.2010.03761.x. Epub 2010 Jan 21. J Thromb Haemost. 2010. PMID: 20088924 Free article. Review.
Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura.
Cataland SR, Peyvandi F, Mannucci PM, Lämmle B, Kremer Hovinga JA, Machin SJ, Scully M, Rock G, Gilbert JC, Yang S, Wu H, Jilma B, Knoebl P. Cataland SR, et al. Among authors: peyvandi f. Am J Hematol. 2012 Apr;87(4):430-2. doi: 10.1002/ajh.23106. Epub 2012 Feb 24. Am J Hematol. 2012. PMID: 22367751 Free article. Clinical Trial. No abstract available.
Residual plasmatic activity of ADAMTS13 is correlated with phenotype severity in congenital thrombotic thrombocytopenic purpura.
Lotta LA, Wu HM, Mackie IJ, Noris M, Veyradier A, Scully MA, Remuzzi G, Coppo P, Liesner R, Donadelli R, Loirat C, Gibbs RA, Horne A, Yang S, Garagiola I, Musallam KM, Peyvandi F. Lotta LA, et al. Among authors: peyvandi f. Blood. 2012 Jul 12;120(2):440-8. doi: 10.1182/blood-2012-01-403113. Epub 2012 Apr 23. Blood. 2012. PMID: 22529288 Free PMC article.
Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies.
Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ; British Committee for Standards in Haematology. Scully M, et al. Among authors: peyvandi f. Br J Haematol. 2012 Aug;158(3):323-35. doi: 10.1111/j.1365-2141.2012.09167.x. Epub 2012 May 25. Br J Haematol. 2012. PMID: 22624596 Free article. No abstract available.
731 results